
(HealthDay News) – A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers. The monoclonal antibody shot would protect against respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, the New York Times reported. It could also… read on > read on >